[Federal Register Volume 77, Number 21 (Wednesday, February 1, 2012)]
[Notices]
[Pages 5026-5027]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2012-2143]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    The meeting announced below concerns Identifying Reasons for 
Racial/Ethnic Disparities with Completing the HPV Vaccine Series among 
Adolescent Females, IP12-004, and Intervention Study to Increase Use of 
Standing Orders Programs for Vaccinating Adults in Physician Office 
Settings, IP12-005, initial review.
    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act

[[Page 5027]]

(Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) 
announces the aforementioned meeting:

    Time and Date: 8 a.m.-5 p.m., May 3, 2012 (Closed).
    Place: Sheraton Gateway Hotel Atlanta Airport, 1900 Sullivan 
Road, Atlanta, Georgia 30337, Telephone: (770) 997-1100.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters To Be Discussed: The meeting will include the initial 
review, discussion, and evaluation of applications received in 
response to ``Identifying Reasons for Racial/Ethnic Disparities with 
Completing the HPV Vaccine Series among Adolescent Females, FOA 
IP12-004; and Intervention Study to Increase Use of Standing Orders 
Programs for Vaccinating Adults in Physician Office Settings, FOA 
IP12-005.''
    Contact Person for More Information: Gregory Anderson, M.S., 
M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., 
Mailstop E60, Atlanta, Georgia 30333, Telephone: (404) 718-8833.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: January 25, 2012.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention.
[FR Doc. 2012-2143 Filed 1-31-12; 8:45 am]
BILLING CODE 4163-18-P